Nimotuzumab inoperable esophageal epithelial tumors, Phase IV |
COURAGE Study |
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
Biograft-G in Dentistry |
Dermofural-diabetic foot ulcers |
Determination of the local inflammatory response in patients with COPD by wood smoke and COPD per cigarette |
CIGB-370 in patients with malignant tumors |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
Vaxira as adjuvant treatment for non-small cell lung cancer |
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
CIMAvax-EGF vaccine Predictor Phase IV |
Dose scale-up and cohort expansion with the therapeutic mAb 14F7 |
Study of the meningococcal ACW135 polysaccharide vaccine |
EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
Seawater-Rhinitis-Children-Phase III |
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
SURFACEN in ARDS. Adults. Phase IV |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
Safety and pharmacokinetics of CIGB-552 |